Skip to main content

Table 4 Estimated effect of the integrated TB/HIV treatment and care intervention, and other covariates, on ART initiation by 8 weeks (N = 473)

From: Integrating HIV care and treatment into tuberculosis clinics in Lusaka, Zambia: results from a before-after quasi-experimental study

Characteristic Unadjusted p-value Adjusteda p-value
HR 95% CI HR 95% CI
Integration Intervention
 After 1.25 (0.95, 1.66) 0.12 1.33 (1.00, 1.77) 0.05
 Before 1.00      
Sex
 Female 0.82 (0.62, 1.09) 0.18 0.84 (0.63, 1.12) 0.23
 Male 1.00      
Age
 ≥ 35 years 1.21 (0.91, 1.60) 0.19 1.17 (0.89, 1.56) 0.26
 < 35 years 1.00      
Clinic
 Clinic B 0.73 (0.55, 0.97) 0.03 0.71 (0.53, 0.94) 0.02
 Clinic A 1.00      
TB Site
 Extra-pulmonary 0.79 (0.53, 1.17) 0.24 0.81 (0.55, 1.20) 0.29
 Pulmonary 1.00      
TB Registration Typeb
 Treatment after Default, Failure, OR Relapse 0.89 (0.60, 1.33) 0.57 0.84 (0.56, 1.26) 0.40
 New 1.00      
  1. HR Hazard ratio, TB Tuberculosis
  2. aHR estimated by Cox proportional hazard modelling, adjusting for remaining variables presented in the table
  3. bRelapse, treatment after default, and failure were collapsed into one category due to collinearity in the model